Relmada Therapeutics
Latest round
- Series A
Last raised
- Jul 2012
Total raised
- $3M
Investors
- 2
About Relmada Therapeutics
Founded in 2004 and based in New York, US, Relmada Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company that develops orally-administered medications for chronic pain associated with depression, central nervous system, and ophthalmic disorders.
Who invested in Relmada Therapeutics
2 investors across 1 round
See all investors in Relmada Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 24, 2012
Amount
$3M
Investors
Questions about Relmada Therapeutics
Who invested in Relmada Therapeutics?
Relmada Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Relmada Therapeutics raised?
Relmada Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Relmada Therapeutics last raise money?
Relmada Therapeutics's most recent round on record is a Series A, in Jul 2012.
What does Relmada Therapeutics do?
Founded in 2004 and based in New York, US, Relmada Therapeutics, Inc.
Where is Relmada Therapeutics headquartered?
Relmada Therapeutics is headquartered in New York, US.
Which VCs invest in companies like Relmada Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Relmada Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Relmada Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.